Dimensional Fund Advisors
TYRA icon

Dimensional Fund Advisors’s Tyra Biosciences TYRA Stock Holding History

Dimensional Fund Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.52M Sell
91,826
-3,814
-4% -$123K ﹤0.01% 2594
2025
Q4 		$2.51M Buy
95,640
+55,961
+141% +$1.03M ﹤0.01% 2690
2025
Q3 		$555K Sell
39,679
-2,002
-5% -$22.8K ﹤0.01% 2977
2025
Q2 		$399K Buy
41,681
+6,969
+20% +$66.2K ﹤0.01% 3027
2025
Q1 		$323K Sell
34,712
-3,269
-9% -$42.3K ﹤0.01% 3064
2024
Q4 		$528K Buy
37,981
+28,074
+283% +$509K ﹤0.01% 3028
2024
Q3 		$233K Buy
+9,907
New +$208K ﹤0.01% 3145
2024
Q2 		– Sell
-10,750
Closed -$176K – 3412
2024
Q1 		$176K Buy
10,750
+141
+1% +$2.31K ﹤0.01% 3202
2023
Q4 		$147K Hold
10,609
– – ﹤0.01% 3240
2023
Q3 		$146K Buy
10,609
+8
+0.1% +$119 ﹤0.01% 3265
2023
Q2 		$181K Buy
+10,601
New +$154K ﹤0.01% 3252

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Dimensional Fund Advisors's TYRA Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Tyra Biosciences (TYRA) stake by 4% in Q1 2026, selling an estimated $123K and leaving 91,826 shares worth $3.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

Dimensional Fund Advisors first reported a position in TYRA in Q2 2023 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Dimensional Fund Advisors held 91,826 shares of Tyra Biosciences worth $3.52M as of Q1 2026.
  • Dimensional Fund Advisors sold 3,814 Tyra Biosciences shares in Q1 2026, an estimated $123K.
  • Tyra Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2594 holding.
  • Dimensional Fund Advisors first reported a position in Tyra Biosciences in Q2 2023 and has held it in 11 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.